CD4 and diabetes mellitus: FABP9 was significantly correlated with “putative role of Tregs in COPD”, “breakdown of CD4+ T-cell peripheral tolerance in type 1 diabetes mellitus”, and “immune response_IL-16 signaling pathway” in the development of CRC (Figure S8, Table S9).